Subtype specificity of anti-HBs antibodies produced by human B-cell lines isolated from normal individuals vaccinated with recombinant hepatitis B vaccine

Author： Shokrgozar M.A.   Shokri F.  

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.20, Iss.17, 2002-05, pp. : 2215-2220

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Persistence of anti-HBs antibodies in health care personnel vaccinated with plasma-derived hepatitis B vaccine and response to recombinant DNA HB booster vaccine

By Trivello R.   Chiaramonte M.   Ngatchu T.   Baldo V.   Majori S.   Moschen M.E.   Simoncello I.   Renzulli G.   Naccarato R.  

Vaccine, Vol. 13, Iss. 2, 1995-02 ,pp. : 139-141

Elsevier

Access to resources Recommend Favorite

Quantification of hepatitis B vaccine-induced antibodies as a predictor of anti-HBs persistence

By Gesemann M.   Scheiermann N.  

Vaccine, Vol. 13, Iss. 5, 1995-01 ,pp. : 443-447

Elsevier

Access to resources Recommend Favorite

Long-term persistence of anti-HBs after vaccination with a recombinant DNA yeast-derived hepatitis B vaccine: 8-year results

By Van Herck K.   Van Damme P.   Thoelen S.   Meheus A.  

Vaccine, Vol. 16, Iss. 20, 1998-12 ,pp. : 1933-1935

Elsevier

Access to resources Recommend Favorite

Anti-HBs characteristics after hepatitis B immunisation with plasma-derived and recombinant DNA-derived vaccines

By Heijtink R.A.   van Bergen P.   Paulij W.P.   de Man R.A.   Osterhaus A.D.M.E.  

Vaccine, Vol. 18, Iss. 15, 2000-02 ,pp. : 1531-1538

Elsevier

Access to resources Recommend Favorite

Persistence of anti-HBs in children vaccinated against viral hepatitis B in the first year of life: follow-up at 5 and 10 years

By Da Villa G.   Peluso F.   Picciotto L.   Bencivenga M.   Elia S.   Pelliccia M.G.  

Vaccine, Vol. 14, Iss. 16, 1996-11 ,pp. : 1503-1505

Elsevier

Access to resources Recommend Favorite